Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Oncogene
|
April 20, 2005
DNA replication and progression through S phase
David Y Takeda, Anindya Dutta
Cancer Cell
|
September 30, 2022
Unpacking circulating tumor DNA lends insight into prostate cancer biology and the clonal dynamics of metastasis
David Y Takeda, Adam G Sowalsky
The Journal of Biological Chemistry
|
April 28, 2005
Degradation of Cdt1 during S phase is Skp2-independent and is required for efficient progression of mammalian cells through S phase
David Y Takeda, Jeffrey D Parvin, Anindya Dutta
Genes & Development
|
December 3, 2005
Recruitment of ORC or CDC6 to DNA is sufficient to create an artificial origin of replication in mammalian cells
David Y Takeda, Yoshiyuki Shibata, Jeffrey D Parvin, et al.
Nature Communications
|
November 20, 2025
Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry
Shan Li, Kaniz Fatema, Nidharshan Sundarraj, et al.
The Prostate
|
November 1, 2014
Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting
Andrea K Miyahira, Haydn T Kissick, Jennifer L Bishop, et al.
Cell Reports
|
February 15, 2025
CRISPR screening identifies regulators of enhancer-mediated androgen receptor transcription in advanced prostate cancer
Rachel R Xiang, Shin-Ai Lee, Caroline F Tyndall, et al.
British Journal of Cancer
|
June 29, 2016
Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
Joaquim Bellmunt, Chensheng Willa Zhou, Stephanie A Mullane, et al.
British Journal of Cancer
|
September 18, 2018
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma
Joaquim Bellmunt, Aly-Khan A Lalani, Sussana Jacobus, et al.
Nature Genetics
|
October 13, 2015
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Mark M Pomerantz, Fugen Li, David Y Takeda, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Oncogene
|
April 20, 2005
DNA replication and progression through S phase
David Y Takeda, Anindya Dutta
Cancer Cell
|
September 30, 2022
Unpacking circulating tumor DNA lends insight into prostate cancer biology and the clonal dynamics of metastasis
David Y Takeda, Adam G Sowalsky
The Journal of Biological Chemistry
|
April 28, 2005
Degradation of Cdt1 during S phase is Skp2-independent and is required for efficient progression of mammalian cells through S phase
David Y Takeda, Jeffrey D Parvin, Anindya Dutta
Genes & Development
|
December 3, 2005
Recruitment of ORC or CDC6 to DNA is sufficient to create an artificial origin of replication in mammalian cells
David Y Takeda, Yoshiyuki Shibata, Jeffrey D Parvin, et al.
Nature Communications
|
November 20, 2025
Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry
Shan Li, Kaniz Fatema, Nidharshan Sundarraj, et al.
The Prostate
|
November 1, 2014
Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting
Andrea K Miyahira, Haydn T Kissick, Jennifer L Bishop, et al.
Cell Reports
|
February 15, 2025
CRISPR screening identifies regulators of enhancer-mediated androgen receptor transcription in advanced prostate cancer
Rachel R Xiang, Shin-Ai Lee, Caroline F Tyndall, et al.
British Journal of Cancer
|
June 29, 2016
Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy
Joaquim Bellmunt, Chensheng Willa Zhou, Stephanie A Mullane, et al.
British Journal of Cancer
|
September 18, 2018
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma
Joaquim Bellmunt, Aly-Khan A Lalani, Sussana Jacobus, et al.
Nature Genetics
|
October 13, 2015
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Mark M Pomerantz, Fugen Li, David Y Takeda, et al.
Page
of 3